Catalyst Funds Management Pty LTD Medtronic PLC Transaction History

Catalyst Funds Management Pty LTD

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$76.84 - $91.03 $2.49 Million - $2.95 Million	32,400 New	32,400 $2.92 Billion
Q2 2024 Dec 17, 2024	SELL	$78.71 - $87.02 $2.27 Million - $2.51 Million	-28,800 Reduced 88.89%	3,600 $283 Million
Q1 2024 Dec 04, 2024	SELL	$82.84 - $88.09 $2.34 Million - $2.49 Million	-28,300 Reduced 87.35%	4,100 $357 Million

2,447

1.06B

10.3M

9.61M

Ticker MDT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,329,149,952
Market Cap $119B
Description
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...

Get notified when there are updates to the investment portfolio of Catalyst Funds Management Pty LTD, based on Form 13F filings with the SEC.

Stay updated on Catalyst Funds Management Pty LTD with notifications on news.